Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Tear production" is not a specific molecule or receptor but rather a **physiological process** primarily mediated by the **lacrimal gland**, an exocrine structure located above each eyeball. The main function of the lacrimal gland is to secrete **lacrimal fluid**—a complex mixture of water, ions, proteins such as lactoferrin and lysozyme, immunoglobulin A (IgA), growth factors like EGF and TGF-beta, and other components—onto the ocular surface[1][3]. This fluid forms the aqueous layer of the tear film that lubricates, protects against infection, nourishes the cornea/conjunctiva, and facilitates wound healing[1][3][6]. Tear secretion is regulated by neural pathways involving sensory input from the cornea/conjunctiva triggering reflexes via parasympathetic fibers from the facial nerve[3]. The balance between basal secretion and drainage maintains ocular surface health; disruption can lead to dry eyes or excessive tearing[4][6]. Because "tear production" refers to a physiological output rather than a discrete molecular target such as a receptor or enzyme—and because it encompasses multiple cell types (acinar cells for water/protein secretion; plasma cells for IgA) as well as complex regulatory mechanisms—it should not be considered a canonical therapeutic target. Instead, interventions typically address underlying dysfunctions in this system using lubricating agents ("artificial tears") rather than drugs targeting specific molecules. In summary: "Tear production" is not itself a molecule/receptor but describes secretory activity mainly attributed to the **lacrimal gland**. For structured data purposes regarding drug targets or molecular biology databases, this entry would be flagged as incorrect since it does not correspond to an individual protein/gene/receptor/enzyme but instead denotes an organ-level function[1][3][6].
Lubrication and moisture replacement for deficient tear production
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lacrimal gland.